RESPIRATORY SYNCYTIAL VIRUS INFECTION
Clinical trials for RESPIRATORY SYNCYTIAL VIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY SYNCYTIAL VIRUS INFECTION trials appear
Sign up with your email to follow new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One shot, three viruses? new vaccine trial targets RSV, hMPV, and PIV3 in seniors
⭐️ VACCINE ⭐️ CompletedThis Phase 1 study tests a new vaccine that aims to protect against three respiratory viruses at once: RSV, hMPV, and PIV3. The trial involves 390 adults aged 60 and older and will check if the vaccine is safe and helps the body produce antibodies. Different combinations and dose…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTION
Phase: PHASE1 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:23 UTC
-
New combo vaccine targets two respiratory viruses in seniors
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine designed to protect against two respiratory viruses: RSV and hMPV. It involved 646 healthy adults aged 60 and older who received either the vaccine or a placebo. The goal was to see if the vaccine is safe and triggers a strong immune response, with…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTION
Phase: PHASE1, PHASE2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 11:01 UTC
-
New RSV vaccine shows promise for seniors in large trial
⭐️ VACCINE ⭐️ CompletedThis study tested an experimental RSV vaccine in about 4500 adults aged 60 and older. Half received the vaccine and half received a placebo shot. The goal was to see if the vaccine could prevent lower respiratory tract disease caused by RSV, a common virus that can be serious in …
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTION
Phase: PHASE2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 11:00 UTC
-
New nasal spray vaccine for RSV shows promise in young children
⭐️ VACCINE ⭐️ CompletedThis study tested a live, weakened RSV vaccine given as a nasal spray to infants and toddlers aged 6 to 24 months in Puerto Rico. The main goal was to see if the vaccine virus spreads from vaccinated children to others in the same household or daycare, and to check how long the v…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTION
Phase: PHASE1, PHASE2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:14 UTC
-
Double-Duty mRNA vaccine targets RSV and hMPV in early trial
⭐️ VACCINE ⭐️ CompletedThis early-stage trial tested an experimental mRNA vaccine designed to protect against two respiratory viruses: RSV and hMPV. Healthy adults aged 18 to 49 and 60 years and older received a single injection of the vaccine at different doses. The main goals were to check safety and…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTION
Phase: PHASE1 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 16:03 UTC
-
New nasal spray vaccine shows promise against RSV in young children
⭐️ VACCINE ⭐️ CompletedThis study tested a live-attenuated RSV vaccine given as a nasal spray in 259 infants and toddlers aged 6 to 18 months. The main goals were to check safety and measure the immune response. Researchers also looked at how much vaccine virus was shed and how well the vaccine worked …
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTION
Phase: PHASE1, PHASE2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 15:16 UTC
-
New study tests best way to protect babies from RSV
Prevention CompletedThis study looked at two new ways to prevent RSV, a serious lung infection in babies: a vaccine given to pregnant women and an antibody shot given to infants. Researchers wanted to see how well each method works alone or together. 181 mother-infant pairs took part, and the study …
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTION
Phase: PHASE4 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Prevention
Last updated Jun 27, 2026 12:32 UTC
-
New RSV shot shows promise in protecting infants
Prevention CompletedThis large study tested a new medicine called clesrovimab to prevent RSV, a serious lung infection, in healthy babies born early or full-term. Over 3,600 infants received either the medicine or a placebo. The goal was to see if the medicine could reduce the number of babies who g…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTION
Phase: PHASE2, PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Prevention
Last updated Jun 27, 2026 09:04 UTC
-
RSV study seeks immune clues in older adults
Knowledge-focused CompletedThis study looked at how the immune system of healthy adults aged 65-75 responds to RSV, a common cause of chest infections. Researchers gave volunteers a mild RSV infection and took blood and nose samples to find immune markers linked to protection. The goal is to use these find…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTION
Phase: NA • Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC